...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Innovations: technology and techniques in cardiothoracic and vascular surgery >Current Clinical Evidence on Rapid Deployment Aortic Valve Replacement: Sutureless Aortic Bioprostheses.
【24h】

Current Clinical Evidence on Rapid Deployment Aortic Valve Replacement: Sutureless Aortic Bioprostheses.

机译：快速部署主动脉瓣置换术的当前临床证据：无缝合的主动脉生物假体。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aortic stenosis is the most common valvular heart disease in the Western world. It is caused primarily by age-related degeneration and progressive calcification typically detected in patients 65 years and older. In patients presenting with symptoms of heart failure, the average survival rate is only 2 years without appropriate treatment. Approximately one half of all patients die within the first 2 to 3 years of symptom onset. In addition, the age of the patients presenting for aortic valve replacement (AVR) is increased along with the demographic changes. The Society of Thoracic Surgeons (STS) database shows that the number of patients older than 80 years has increased from 12% to 24% during the past 20 years. At the same time, the percentage of candidates requiring AVR as well as concomitant coronary bypass surgery has increased from 5% to 25%. Surgical AVR continues to be the criterion standard for treatment of aortic stenosis, improving survival and quality of life. Recent advances in prosthetic valve technology, such as transcatheter AVR, have expanded the indication for AVR to the extreme high-risk population, and the most recent surgical innovation, rapid deployment AVR, provides an additional tool to the surgeons' armamentarium.
机译：主动脉瓣狭窄是西方世界最常见的瓣膜性心脏病。它主要是由年龄相关的变性和通常在65岁以上的患者中发现的进行性钙化引起的。在出现心力衰竭症状的患者中，未经适当治疗的平均存活率仅为2年。所有患者中约有一半在症状发作的前2至3年内死亡。此外，主动脉瓣置换术（AVR）的患者年龄随着人口变化而增加。胸外科医师协会（STS）数据库显示，在过去20年中，80岁以上的患者人数从12％增加到24％。同时，需要AVR以及同时进行冠状动脉搭桥手术的候选人比例从5％增加到25％。外科AVR仍然是治疗主动脉瓣狭窄，提高生存率和生活质量的标准标准。人工瓣膜技术的最新进展，例如经导管AVR，已将AVR的适应症扩大到极高风险人群，最新的外科手术创新，即快速部署AVR，为外科医生的武器库提供了额外的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号